九安医疗
(002432)
| 流通市值：264.16亿 | | | 总市值：281.53亿 |
| 流通股本：4.37亿 | | | 总股本：4.66亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 531,269,303.32 | 301,482,711.39 | 1,365,588,936.68 | 1,069,311,569.11 |
| 营业总成本 | 770,112,149.83 | 361,006,778.84 | 1,634,094,344.46 | 1,275,596,464.12 |
| 其他经营收益 | | | | |
| 营业利润 | 3,526,432,333.37 | 389,807,214.71 | 2,535,392,352.3 | 1,595,068,871.16 |
| 利润总额 | 3,522,588,101.66 | 385,861,006.42 | 2,527,258,849.57 | 1,596,307,146.21 |
| 净利润 | 3,074,211,967.55 | 304,457,207.99 | 2,269,504,490.99 | 1,587,758,433.66 |
| 每股收益 | | | | |
| 其他综合收益 | -1,094,749,924.08 | -510,988,207.81 | -504,390,801.11 | 81,832,104.69 |
| 综合收益总额 | 1,979,462,043.47 | -206,530,999.82 | 1,765,113,689.88 | 1,669,590,538.35 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 9,636,809,548.07 | 13,381,885,621.44 | 11,935,688,000.11 | 15,222,829,419.9 |
| 非流动资产: | | | | |
| 非流动资产合计 | 24,113,650,222.1 | 16,525,801,611.94 | 17,375,169,000.77 | 13,758,791,392.41 |
| 资产总计 | 33,750,459,770.17 | 29,907,687,233.38 | 29,310,857,000.88 | 28,981,620,812.31 |
| 流动负债: | | | | |
| 流动负债合计 | 6,943,348,461.79 | 4,560,293,157.42 | 4,509,674,513.26 | 3,189,095,554.21 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,474,433,230.22 | 3,522,046,024.78 | 2,766,268,915.78 | 3,371,509,709.02 |
| 负债合计 | 10,417,781,692.01 | 8,082,339,182.2 | 7,275,943,429.04 | 6,560,605,263.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 23,140,851,693.08 | 21,617,476,644.03 | 21,832,159,034.25 | 22,189,231,323.9 |
| 股东权益合计 | 23,332,678,078.16 | 21,825,348,051.18 | 22,034,913,571.84 | 22,421,015,549.08 |
| 负债和股东权益合计 | 33,750,459,770.17 | 29,907,687,233.38 | 29,310,857,000.88 | 28,981,620,812.31 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 648,570,187.24 | 320,245,779.59 | 1,618,362,419.42 | 1,222,138,963.14 |
| 经营活动现金流出小计 | 762,281,472.64 | 412,721,047.32 | 1,785,165,636.32 | 1,256,207,811.73 |
| 经营活动产生的现金流量净额 | -113,711,285.4 | -92,475,267.73 | -166,803,216.9 | -34,068,848.59 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 16,511,725,781.26 | 7,615,562,869.47 | 11,305,763,442.52 | 9,275,809,471.95 |
| 投资活动现金流出小计 | 19,266,527,924.58 | 8,644,560,063.58 | 12,034,209,566.98 | 9,939,251,224.42 |
| 投资活动产生的现金流量净额 | -2,754,802,143.32 | -1,028,997,194.11 | -728,446,124.46 | -663,441,752.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 10,740,115,272.86 | 4,416,408,569.36 | 9,132,931,270.62 | 7,106,440,878.06 |
| 筹资活动现金流出小计 | 8,393,523,764.18 | 3,527,873,274.72 | 8,609,237,821.15 | 6,227,292,227.49 |
| 筹资活动产生的现金流量净额 | 2,346,591,508.68 | 888,535,294.64 | 523,693,449.47 | 879,148,650.57 |
| 汇率变动对现金及现金等价物的影响 | -89,912,516.57 | -48,011,943.18 | -71,077,725.24 | -36,864,029.35 |
| 现金及现金等价物净增加额 | -611,834,436.61 | -280,949,110.38 | -442,633,617.13 | 144,774,020.16 |
| 期末现金及现金等价物余额 | 1,781,160,796.78 | 2,112,046,123.01 | 2,392,995,233.39 | 2,980,402,870.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -611,834,436.61 | - | -442,633,617.13 | - |
最新报告期：2026-09-22| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华创证券 | 郑辰,张良龙,李婵娟 | 9.89 | 9.76 | 10.95 | 2026-09-22 |